<SEC-DOCUMENT>0001214659-18-004668.txt : 20180702
<SEC-HEADER>0001214659-18-004668.hdr.sgml : 20180702
<ACCEPTANCE-DATETIME>20180702110908
ACCESSION NUMBER:		0001214659-18-004668
CONFORMED SUBMISSION TYPE:	PX14A6G
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20180702
DATE AS OF CHANGE:		20180702
EFFECTIVENESS DATE:		20180702

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MCKESSON CORP
		CENTRAL INDEX KEY:			0000927653
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		IRS NUMBER:				943207296
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		PX14A6G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13252
		FILM NUMBER:		18931591

	BUSINESS ADDRESS:	
		STREET 1:		ONE POST ST
		STREET 2:		MCKESSON PLAZA
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94104
		BUSINESS PHONE:		4159838300

	MAIL ADDRESS:	
		STREET 1:		ONE POST ST
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94104

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MCKESSON HBOC INC
		DATE OF NAME CHANGE:	19990115

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MCKESSON CORP
		DATE OF NAME CHANGE:	19950209

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SP VENTURES INC
		DATE OF NAME CHANGE:	19940728

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UAW Retiree Medical Benefits Trust
		CENTRAL INDEX KEY:			0001480561
		IRS NUMBER:				900424876
		STATE OF INCORPORATION:			XX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		PX14A6G

	BUSINESS ADDRESS:	
		STREET 1:		200 WALKER STREET
		CITY:			DETROIT
		STATE:			MI
		ZIP:			48207
		BUSINESS PHONE:		313-324-5928

	MAIL ADDRESS:	
		STREET 1:		200 WALKER STREET
		CITY:			DETROIT
		STATE:			MI
		ZIP:			48207
</SEC-HEADER>
<DOCUMENT>
<TYPE>PX14A6G
<SEQUENCE>1
<FILENAME>g72180px14a6g.htm
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: Securex Filings LLC
    Document created using EDGARfilings PROfile 4.4.0.0
    Copyright 1995 - 2018 Broadridge-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" bgcolor="#ffffff" text="#000000">
<div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">July 2, 2018</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Dear Fellow McKesson Shareholders,</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">We urge you to</font>&#160;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">vote FOR the following three shareholder resolutions at the annual meeting for McKesson Corporation (NYSE:MCK) on July 25, 2018:</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: left">&#160;</div>

<div style="TEXT-ALIGN: left">
<table id="z7b4ca5ed0aed45c9999c5dd5268259bd" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Disclosure of Lobbying Activities and Expenditures (Item 4)&#160;</font>submitted by the UAW Retiree Medical Benefits Trust and co-sponsored by the Rhode Island Employees&#8217; Retirement Systems Pooled Trust, United Church Funds and Trinity Health.</div>
</td>
</tr>
</table>
</div>

<div><br>
</div>

<div style="TEXT-ALIGN: left">
<table id="z2edf1209b95a451297cdac0383556a99" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Accelerated Vesting of Equity Awards (Item 5)&#160;</font>submitted by the International Brotherhood of Teamsters.</div>
</td>
</tr>
</table>
</div>

<div><br>
</div>

<div style="TEXT-ALIGN: left">
<table id="z192a6abcce7b462e87917e86707c654e" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 18pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; VERTICAL-ALIGN: top; WIDTH: 18pt; align: right">&#183;</td>
<td style="VERTICAL-ALIGN: top; TEXT-ALIGN: left; WIDTH: auto">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Adoption of a Policy to Use GAAP Calculations to Determine Executive Compensation Awards When Awards are Based on GAAP Metrics (Item 6)&#160;</font>submitted by the AFL-CIO Equity Index Fund and co-sponsored by As You Sow, the Oregon Department of State Lands, and the Oregon Public Employees Retirement System.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">These reforms were recommended to McKesson by the Investors for Opioid Accountability (IOA), a diverse coalition that includes state treasurers, publicly elected comptrollers, asset managers, faith-based, public and labor funds.&#160; We are members of the IOA, which was established in response to concerns for the threats to shareholder value stemming from the opioid crisis.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center"><u>MCKESSON FACES MOUNTING FINANCIAL, LEGAL, AND REPUTATIONAL RISKS</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">As one of the top three drug wholesale distributors in the United States, McKesson is at a critical juncture.&#160; The company faces mounting financial, legal, and reputational risks stemming from allegations that it helped fuel the nation&#8217;s opioid epidemic by failing to identify, report, and prevent the filling of suspicious drug orders, as required by law.</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Last year, McKesson agreed to a precedent-setting $150 million settlement with the Department of Justice and Drug Enforcement Agency (DEA) for failure to report suspicious orders and for violations of a prior settlement of similar allegations in 2008.&#160; The company now faces hundreds of lawsuits that have been consolidated in an Ohio federal court, investigations by a coalition of 41 state attorneys general, and Congressional inquiries related to its distribution practices.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">1</sup>&#160; These developments have industry watchers drawing parallels to the tobacco litigation of two decades ago and the master settlement, which cost the cigarette industry hundreds of billions of dollars.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">2</sup></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">_____________________________</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller">1</sup> 2018 Form 10-K, p. 121, available at <a style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" href="http://www.sec.gov/Archives/edgar/data/927653/000092765318000010/mck_10kx3312018.htm">https://www.sec.gov/Archives/edgar/data/927653/000092765318000010/mck_10kx3312018.htm</a>.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller">2</sup> Tobacco Control Legal Consortium, The Master Settlement Agreement: An Overview, <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #0563c1"><u>http://www.publichealthlawcenter.org/sites/default/files/resources/tclc-fs-msa-overview-2015.pdf</u></font></div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">In West Virginia alone, a Pulitzer Prize-winning report uncovered that in 2012 alone, McKesson had distributed 10,282,060 oxycodone pills to that state.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">3</sup>&#160; More recently, the House Energy and Commerce Committee found that McKesson supplied more 5 million opioid pills to Kermit, a town of merely 400 residents, from 2006-2007.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">4</sup></div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Preventing the diversion of controlled substances to illicit markets is core to drug distributors&#8217; operational mandate, so the growing concern that McKesson may have distributed excessive quantities of prescription opioids creates the potential for enhanced legal scrutiny over McKesson&#8217;s opioid business activities.&#160; Against this backdrop, we believe that the governance reforms suggested in the following proposals are urgently required.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center"><u>Vote&#160;FOR&#160;Disclosure of Lobbying Activities and Expenditures (Item 4).</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">McKesson&#8217;s lobbying disclosure falls short on several aspects of lobbying important to investors. McKesson does not disclose state level expenditures in states that do not legally mandate such disclosure, nor does the company report on the portion of dues paid to lobbying organizations of which McKesson is a member that is used for lobbying.</div>

<div>&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">From 2010-2017, McKesson spent $13,776,477 on direct federal lobbying.</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller">5</sup><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160; This figure does not include state lobbying expenditures, where McKesson hired 47 lobbyists in 14 states in 2016.</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller">6</sup><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160; Identifying state level expenditures has been described as &#8220;nearly impossible&#8221; because &#8220;the &#8216;Byzantine&#8217; manner in which the data is captured and made available onlin</font>e effectively buries information<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"> at many states.&#8221;</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;FONT-FAMILY: 'Times New Roman', serif">7</sup><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">_____________________________</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller">3</sup> Eric Eyre, Drug Firms Poured 780M Painkillers into WV Amid Rise of Overdoses, Dec. 17, 2016, Charleston Gazette-Mail, available at <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #0563c1"><u>https://www.wvgazettemail.com/news/cops_and_courts/drug-firms-poured-m-painkillers-into-wv-amid-rise-of/article_99026dad-8ed5-5075-90fa-adb906a36214.html</u></font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller">4</sup> Eric Eyre, Drug Firm CEO Not Expected to Answer Questions About WV Opioid Probe, March 22, 2018, Charleston Gazette-Mail, available at <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #0563c1"><u>https://www.wvgazettemail.com/news/health/wv_drug_abuse/drug-firm-ceo-not-expected-to-answer-questions-about-wv/article_0ecc25d7-3588-54f7-ac05-83b70a709115.html</u></font>.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller">5</sup> Open Secrets, accessed June 18, 2018, available at <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #0563c1"><u>https://www.opensecrets.org/lobby/clientsum.php?id=D000022105&amp;year=2017</u></font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller">6</sup> Followthemoney.org, &#8220;McKesson Corp.,&#8221; accessed June 18, 2018. Lobbyists must register on behalf of their clients, but lobbyists are not mandated to disclose all of their expenditures in 33 states.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller">7</sup> Nathan Layne, &#8220;Wal-Mart improves lobbying disclosure after shareholder push,&#8221; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Reuters</u></font>, May 13, 2015.</div>

<div>&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div>&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">McKesson shareholders also face a blind spot when it comes to trade association lobbying expenditures. The company states it has implemented a policy restricting its trade associations from using its payments for political contributions, which includes campaign related expenses but not lobbying expenditures.&#160; Unlike Merck, Johnson &amp; Johnson and United Healthcare, McKesson does not disclose the amount of its trade association membership fees used for lobbying purposes.</div>

<div>&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">McKesson lists membership in 13 trade associations, which collectively spent over $30 million on federal lobbying for 2017.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">8</sup>&#160; We are concerned that the company&#8217;s involvement in the Healthcare Distribution Alliance (HDA) presents reputational risks from the HDA&#8217;s role in passing legislation that weakened the DEA&#8217;s ability to stop suspicious drug shipments by distributors, thereby exacerbating the opioid crisis.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">9</sup>&#160; We also are concerned that, according to the Board&#8217;s <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Political Engagement </font>statement<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">&#160;</font>on McKesson&#8217;s website, management oversight does not extend to grants, donations, or sponsorships to organizations, such as patient advocacy and professional organizations, that engage in policy advocacy on issues McKesson has identified as important to its business.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">10</sup>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center"><u>Vote FOR Pro Rata Accelerated Vesting of Equity Awards (Item 5)</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">McKesson has now had two failed advisory say-on-pay votes in the last five years, making changes to the company&#8217;s policy on accelerated vesting of equity awards key to advancing much needed executive pay reforms at the company.&#160; Accelerated vesting of unearned equity awards is inconsistent with the principles of pay and performance as it provides executives a windfall of awards unrelated to performance in the event of a change in control.</div>

<div>&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">_____________________________</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;FONT-FAMILY: 'Times New Roman', serif">8</sup><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;</font>OpenSecrets.org, (Business Roundtable - $27,380,000; Health Industry Distributors Association (HIDA) - $120,000; Healthcare Leadership Council (HLC) - $730,000; Healthcare Distribution Alliance (HDA) - $1,273,232; Senior Care Pharmacy Coalition - $770,000), accessed June 18, 2018.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;FONT-FAMILY: Century, serif">9</sup><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"> &#8220;</font>The Drug Industry&#8217;s Triumph Over the DEA,&#8221; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>Washington Post</u></font>, October 15, 2017, available at <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #0563c1"><u>https://www.washingtonpost.com/graphics/2017/investigations/dea-drug-industry-congress/?utm_term=.151b128a7543</u></font>; &#8220;Opioid Lobbyist Left a Digital Fingerprint on a Campaign by &#8216;Patient Advocates,&#8217;&#8221; <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><u>The Intercept</u></font>, October 22, 2017, available at <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #0563c1"><u>https://theintercept.com/2017/10/22/opioid-lobbyist-left-a-digital-fingerprint-on-a-campaign-by-patient-advocates/</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #0563c1"><u>.</u></font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;FONT-FAMILY: 'Times New Roman', serif">10</sup><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;</font>McKesson Political Engagement, <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #0563c1"><u>http://www.mckesson.com/about-mckesson/public-affairs/political-engagement</u></font>, accessed on June 26, 2018. </div>

<div>&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div>&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">The company&#8217;s &#8220;double trigger&#8221; vesting in the event of a change in control does not prevent McKesson executives from receiving windfalls in a change in control and termination scenario.&#160; By granting the Compensation Committee discretion to allow for pro-rata vesting, executives would receive awards consistent with their performance, thereby better aligning with long-term shareholder interests.&#160; Contrary to the company&#8217;s position that limiting accelerated vesting would make McKesson an outlier, several other major corporations have adopted provisions to allow for pro-rata awards or forfeiture of unearned awards, including Apple, Chevron, and Microsoft.</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center"><u>Vote&#160;FOR&#160;Adoption of a Policy to Use GAAP Calculations to Determine Executive Compensation Awards When Awards are Based on GAAP Metrics&#160;(Item 7)</u></div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">McKesson uses the GAAP metric of Earnings Per Share (EPS) in senior executive cash incentive goals. However, it adjusts the GAAP calculation to exclude litigation and other costs, which insulates executives from the financial impacts of legal and other costs.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">11</sup>&#160; According to this year&#8217;s proxy, for the fiscal year ended March 31, 2018, McKesson reported a diluted EPS figure of $0.30. It then made several adjustments to this figure and reported an <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">adjusted </font>EPS figure of $11.71, which is an <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">adjustment</font> equal to a 3,803% increase from the GAAP calculation.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">12</sup>&#160; A metric that is &#8220;adjusted&#8221; nearly 4,000% is so far removed from the original metric that it might consider a new name altogether. Particularly at a time when McKesson is facing legal claims and settlements, the exclusion of litigation from metrics that drive executive pay severs pay from performance. Incentive pay should incentivize executives to consider legal risks rather than removing them from the calculation.</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">In Appendix A of the 2018 proxy statement, McKesson reports the largest category of adjustments to EPS under the broad heading of &#8220;other adjustments.&#8221; The footnotes include a list of items under this heading that include &#8220;<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; BACKGROUND-COLOR: #ffffff">adjustments to claim and litigation reserves for estimated probable losses.&#8221;</font></div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">The adjusted EPS figure of $11.71 resulted in a payout of $3,477,600 to CEO John H. Hammergren under the Management Incentive Plan. The unadjusted EPS figure of $0.30 would have resulted in a payout of $0.</div>

<div style="TEXT-ALIGN: left"><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Thank you for your support,</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"><img src="millersig.jpg"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Meredith Miller</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Chief Corporate Govern</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">ance Officer</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">UAW Retiree Medical Benefits Trust</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">_____________________________</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;FONT-FAMILY: 'Times New Roman', serif">11</sup><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;</font>2018 Proxy Statement, p. 36, available at <a style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" href="http://www.sec.gov/Archives/edgar/data/927653/000119312518193698/d587392ddef14a.htm">https://www.sec.gov/Archives/edgar/data/927653/000119312518193698/d587392ddef14a.htm</a>.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;FONT-FAMILY: 'Times New Roman', serif">12</sup><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#160;</font>2018 Proxy Statement, p. A-1, available at <a style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" href="http://www.sec.gov/Archives/edgar/data/927653/000119312518193698/d587392ddef14a.htm">https://www.sec.gov/Archives/edgar/data/927653/000119312518193698/d587392ddef14a.htm</a>.</div>

<div>&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; WIDTH: 100%; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div>&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"><img src="magazinersig.jpg"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Seth Magaziner</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Rhode Island General Treasurer</div>

<div>&#160;</div>

<div>&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"><img src="rowansig.jpg"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Cathy Rowan</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Socially Responsible Investments</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Trinity Health</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"><img src="mccloskeysig.jpg"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Katie McCloskey</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Director, Social Responsibility</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">United Church Funds</div>

<div><br>
</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"><img src="zelenkosig.jpg"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Carin Zelenko</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Director, Capital Strategies</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">International Brotherhood of Teamsters</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div><br>
</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">
<hr style="BORDER-TOP: medium none; HEIGHT: 2px; BORDER-RIGHT: medium none; BORDER-BOTTOM: medium none; COLOR: #aaaaaa; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #aaaaaa; MARGIN-RIGHT: auto" align="center" noshade="noshade">
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">THIS IS NOT A PROXY SOLICITATION AND NO PROXY CARDS WILL BE ACCEPTED</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">Please execute and return your proxy card according to McKesson Corporation&#8217;s instructions.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">
<hr style="BORDER-TOP: medium none; HEIGHT: 2px; BORDER-RIGHT: medium none; BORDER-BOTTOM: medium none; COLOR: #000000; TEXT-ALIGN: center; MARGIN-LEFT: auto; BORDER-LEFT: medium none; BACKGROUND-COLOR: #000000; MARGIN-RIGHT: auto" align="center" noshade="noshade">
</div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>magazinersig.jpg
<TEXT>
begin 644 magazinersig.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!F17AI9@  34T *@    @ ! $:  4
M   !    /@$;  4    !    1@$H  ,    !  (   $Q  (    0    3@
M      !@     0   &     !<&%I;G0N;F5T(#0N,"XU /_; $,  0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_  !$( $
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MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$
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M_P#'_P#9YFT\3&,/+!;-K_C3PWJESY39C#OH]L92,I'@C/V.80S25">59/\
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MH8:*J8N32^Q7IX2^W.CS#XI?M1_$']KOPOXA^#?["G@"?QCI7C6PU3PGXO\
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M8J5:52C[+%05-1A5A[2-58:G[TO8X+FA'VE"TIUU!>VKS4ZZJ_D1^QC^TO\
MLU_LY?LEZAIGQ&\=>$/AUXM^'OQ8^-^B_$;X?-.(?&J_$&X^*OB_4H=$T+P$
MN?$VKWFMZ7>:(/#%II.DR)JEO/91V2GYMOUQ^PW8>.X_@0GB/Q_H&O>#]0^(
MWQ#^)_Q/T#P/XGO;N]\0^"/!/C_QMJ_B/P=X7UH7@$EAJ5AH-[:2WFCI^YT:
M>YDTR(LMKN/NEQ\%?@_=^/4^*=U\+/A[<?$N..&*/Q]/X/T"7Q@B6Z/' %\1
M/8-JH,,<CQQ-]JW1H=J$* !Z;7EYYGN7Y@LQG@L'BZ>)SK,H9KF-;&XFG75&
MK'ZU/ZG@84Z5-^P5;&59/$XB<ZU2G##THTZ"A6EB>G!X*O0>'56K2E3P>'>%
MP\*-.4.:+]DG5K.4Y>^XTHI4X)0C*523E-N"IE%%87BCQ/X>\%>&]>\8>+=8
ML/#WA?PQI&H:]X@UW5;A+73=(T?2K66]U#4+VXD(6*VM+6&2:5SD[4(4%B ?
MEH0G4G&G3C*<YRC"$(1<ISG)J,8QBDW*4FTHQ2;;:25STFU%.4FDDFVV[)):
MMMO1)+5M[&9\0/B!X,^%?@OQ)\1/B'XCTSPEX*\(Z7<:SXB\0ZQ<+;6&FV%L
M!NDD<Y>2:61H[>TM($ENKV[F@L[2&>ZGBB?\W/A1\-/&/[<'Q9\,_M9_'33]
M9\/_ +/?@JYAUK]DW]GCQ! MN^K7'E_Z%^T#\6M&;=&_B'4XF^V^ /"M\+@^
M&M.FM]1N2MZP^T<GX'\&^(/^"FGC[0OCK\6;.^TC]ASP#KSZI^SY\$]1BN+*
M;X_^(='N9;>U^-WQ;T^41F?P7#/'+)\/O!5R)+?4+?;J>K1_8KF\L];_ %\C
MC2*-(HD2.*-%CCCC4)''&@"HB(H"HB* JJH"J    *^RKRAPA1JX+#U%/BG$
MTJF'S/$0M*/#^'K14*N5X2KK?.*L'.EFF*I66!IRGEV'J.O+&RAY,$\UG&M.
M+66TYQGAZ<KIX^I%J4,35C_T"0E:6&IR_C22Q%2/(J*?Y(_MD_M0?M8?!3XY
M_"S7++PQX'^'?[(7AWXR_#'P'XZ\7^+_ !7H]GXI^+TGC^!QK5YH:M;ZG'X3
M\!_#>SGGU76KS5!I.HZU?:'<P6MX]FQM:]>U'XX?M#?M9_!_XF:C^QEH?ASX
M=Z-JD^F>&_@_^T%\9+S6]-M/&EI-/>6_C?Q[X)\ 6'A35-53P[HULEO!X \4
MZ[-]G\6ZO+<WL6@1:'IUOJ6I_;_CSX<?#_XI:&GAGXE>"?"WCWP['J-AJZ:'
MXOT+3?$.E)JFES"YT[4%L-4M[JV%Y93@2VUP(_-A?E&&37G7[0/Q[^'/[+OP
MKO\ Q]XR+I9V"VF@>"_!6@6R3>)/'7BR]467A7X>^!="MU\W4M?UZ]^SZ9I=
MA9P&.!7\^80V=O+(E8?-<!C,/D."R[A7"5N(L+6HX6C*$*E7!XY1KTJ].IBL
M#*I.>8YAB:ZJPKSQE9X*EA*M3#PPCI+"_4%4PU>E4QM;$9G5A@*D959Q;C&K
M1;IRA*-.LHQ6'H4X<K@J4%6E4C&<JO-[7V_P3\'?$7[1W[+7[07PB_9[^.O[
M4VA_M%>$O$GP ^*OQ*\=:EKO@+0O ?B'X7Q?#C4=!E7QU?>)+?5;[4_$7AW7
MKO7KK0+JY\374^H2WMK+JJBTA26WA^C_ (%?M\_ #]JR'6?#O[/'CG2M:^)P
M\(^,/$WA[PKXJLM6TZ+[+X>U?_A'-/UGQ ^G079L=%O=7O-#O9[.*X_X2*'0
MM8LKJ72[:XN(X!A?LP?LU>(KS3OBU\9OVK=$T3Q)\:_VH+'^S?'_ (*O3;^(
M_"OP[^$'V:Y@\,_ +31=645OJ&CZ-IE_<#QE-Y'V3Q/XCN;Z^EA,8AKUOXGW
M,'[,WPHTNU_9T_9WL?%GB5KW2?A_\./AOX!T?2?"/A[3[G7)@(KSQ)JUC8I:
M>$O 6BK:?VKXDU3[/*5@LXXK>WN-1GM$/=F]?(\RQT\(L+3QO$#^IX2.8Y9/
M)\CX>KYASXNOF&*KT*.$IX.IA8U\10P4*]*67T:V#R_Z_4Q"EBIVQPD,9AZ,
M:OM)4<#^]JO#XF.+QF/A1:I0H4H3E5E5C5<*<ZTH35>4*V(]A&G:FK_#7[,W
M[4OQHT?]O3QS^QS^T)\<-(^*>KP?!_1_%&ES:1\(+;X=Z#9_%<W">(_%O@[P
M1JEA!+=>(?"_AOP-JFDR)J_B:^?4+Z\2<%;>Z@N+=OH#7_V[=;UR^U.V_9P_
M94^/O[1NE:-?7%A?>/-(T[0_AO\ #:[NK&:6WU"U\->)OB)J.D7_ (KN+65$
M43Z%X?N]&N Y,6LDH%D[']F_]DZ\^'7C+Q#^T'\</%[?%W]J3Q]82Z;XB\;B
M.XL_"'@/PM+="[M?AG\(?#4TCIX<\&Z4$MX;B_N/.\0>)KR"75-6NHUN4TZU
M^U5545410JJ JJH"JJ@8 4#   X  P!7+GN:\,O-8U\+DV&S'V66Y;A<3[*;
MRK)<3FN'I.&98[#8+*\-E>)^JXF:IO"KVN"GS1JUJ].K[:$*>N"PV8K#.%7%
MU*'-B,14I\R6)Q=/#5)*6'HU*V)J8FG[6FN;VGNUE9QA"4>1N7S/\*_VK_A/
M\2/@;:_'K6-5C^%'A:"Y\1Z1XNL/BAJ&C^&M1\"^*/!NKWV@>+?#'B*:34)=
M-35-$UG3KNS<6=[<1W6V*2V+^>B5X/=_\%3?V-OMES;>'?&7CKXA6MI(T,VN
M_#3X.?%;QYX8,Z.Z-!!XD\.>$+W1KN93&69+2\G*QM%*V(YH6?N6_P""<_[%
M4WQ&\0_%34/@%X4UOQ9XH\177BW5X_$5YXA\1>$W\3W[M/J&O67P_P!;UF_\
M":7JE_=LVH7MWIGARTEN=2)U*4M??OZ^R-+TG2M$LH=.T73-/TC3[=52"PTN
MRM["R@545%6&UM(XH(U5$1%"(H"*JCA0!QUJW ]*M4JT,%Q)CZ=:I*I3PT\9
ME^34\#3G:2PJK?5\_K9A[%MTXXN:P,JD8*<\,I3:AK"&<RA&,ZV7T)0BHNHJ
M-?%NLUI[1Q]I@8T.=*[IKVRBW:-2RN_S_P!)_P""JG[#E]J']E:W\7KKX?:C
MYLL+6GQ0\!>/_AVZ21VL=ZJO)XJ\-:; IN+6436N9?\ 2%241[FC=1]\^']>
MT?Q5H.B>)_#U_#JN@>(](TW7M#U.VW_9]2T?6+.'4-,OX/,2.3R;RRN(+B+S
M$1]DB[D5L@1ZIX:\.:WG^VO#^B:OEE<_VII5C?Y9%V(Q^UP2Y9$^13U5?E&!
MQ6TJJBJB*%10%55 5551A551@     # ' KR,SK9%5C1>49?FF!J)R^L+,,U
MPN94Y*RY%1]AE&63@T^;F=1U$URV2=V=6'AC(N7UJOAJRLN1T,-4P\D]>9SY
M\5B$[Z645&SOKLCBOB-\-_ ?Q=\&:W\._B=X3T3QQX&\2)91Z[X6\164>H:/
MJB:=J5GK%@+NTE^20V>JZ?8ZA;-PT-W:03H0\:D:/A'P9X/\ :#I_A7P)X4\
M.>"_#&E0):Z7X=\*:'IOA[0].MDR4@L=*TBVM+&UA4LQ6."!$!8D#)-=+17G
M?6<1]76$]O6^J*M+$+#>UJ?5U7E"%.5=4>;V:K2IPA"53EYW"$(N7+%);^SA
MS^UY(>UY5#VG*N?D3<E#GMS<JDVU&]DVW:[84445B6%%%% !1110 4444 %>
M=_%;X3_#WXW^!=9^&?Q4\-6WC#P)XADTQ]<\-WMWJ5G8ZJ-'U6RUJQ@OFTJ]
ML+FXLTU+3[2:XL7G-G?Q1-:7\%S9S3V\GHE%:T:U;#5J6(P]6K0KT*D*U&O1
MG.E6HU:<E.G5I5(.,Z=2G-*4)PDI1DE*+329,X1J0E"I&,X3BXSA.*E"<9*T
MHRC)-2C)-IIIIK1E:RL[/3K.UT_3[2VL+"QMX;.RL;*"*UL[.TMHUAM[6UMH
M$2&WMX(42*&"%$BBC541550!9HKSCXOZQ\1_#_PP\<:S\(/"%EX^^)]AX>OY
MO O@_4]8L- TW7O$AC\O3;/4-8U.ZL;&QLA,XGNI9[RW#00R11RK+(AHHTY8
MBO2HJ=.,Z]6%-5*]6%&E&56:BIUJ]64:=*FG+FJ5:LXPA&\YR44V$I*G"4FI
M-0BY<L(RG)J*O:$(IRE)I6C&*;D[))MGFW[2O[4/PX_9A\*:;K/C ZGK_BWQ
M=J'_  COPP^%WA.U;5?'WQ0\83JHL?#?A71XLN[R320+?ZK=>3I6D02K/?7*
M%X(9_GO]G3]G+XL^-_B!9?M7?MJMH>I?&BT_M)/@W\'M#G&I_#S]F;PQJADC
M:#1Y7!@\2?%35=.9+;Q3X^D1IH(C+I.AR6]@T@;<_96_9*\5^#=<G_:%_:H\
M66'QH_:U\4V+VUYXG6T7_A"_@[X=N9I;I/AO\%]'GB6+0-&M&N'BUCQ%%!!K
M?B:<,;N9;+$$GWQ7U&+Q^!R/#XC*<BK0Q>+KPGA\VXBA&:^L4Y)QK9?D:J0I
MU<+EE2+=/%8N<(8S-87IM87 3J87$>;2H5L;4IXK&PE2I0:J87 2L^22LX5\
H9RN4:F(BUS4J2;I89VE>I7C&I3****^2/4"BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>mccloskeysig.jpg
<TEXT>
begin 644 mccloskeysig.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!F17AI9@  34T *@    @ ! $:  4
M   !    /@$;  4    !    1@$H  ,    !  (   $Q  (    0    3@
M      !@     0   &     !<&%I;G0N;F5T(#0N,"XU /_; $,  0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_  !$( $L
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MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$
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ML_P9\.?!]C*\9O==\1ZH8X(XXE9;#3H[W5;I4L;"YDC^4_V4#'\'8#XU^/\
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MO;7XJ>(UM-2\/> M%>)Q8//I?A=WUSQ0T@EFLSJ&CVF(GF8M 'TS7SS^T/\
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*BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>millersig.jpg
<TEXT>
begin 644 millersig.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!F17AI9@  34T *@    @ ! $:  4
M   !    /@$;  4    !    1@$H  ,    !  (   $Q  (    0    3@
M      !@     0   &     !<&%I;G0N;F5T(#0N,"XU /_; $,  0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_  !$( "X
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MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$
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MB2W;QQ-/,EM&S*\[Q0(\LBQ*YCB5I7PBM65XJ\4:#X*\/:OXK\4ZMI^@^'-
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MX/\ @GU^S-X_UW0]:3X:?#?X-^'O$_B3XB?$OXM_#CPEJ5\WA/XMV'A#P?\
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3R&J,9]_\^W/K[Y/>G444AG__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>rowansig.jpg
<TEXT>
begin 644 rowansig.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!F17AI9@  34T *@    @ ! $:  4
M   !    /@$;  4    !    1@$H  ,    !  (   $Q  (    0    3@
M      !@     0   &     !<&%I;G0N;F5T(#0N,"XU /_; $,  0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_  !$( "L
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MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$
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)44 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>zelenkosig.jpg
<TEXT>
begin 644 zelenkosig.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!F17AI9@  34T *@    @ ! $:  4
M   !    /@$;  4    !    1@$H  ,    !  (   $Q  (    0    3@
M      !@     0   &     !<&%I;G0N;F5T(#0N,"XU /_; $,  0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_  !$( #H
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MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$
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MQ?8ZG9>$+K4/&@TSP?-XWU;5-!\/^))/#.CZW/H.H01 'Z*9HKB_ /C[P/\
M%#POI7CWX=>+M!\;>#]?MA/I/B#PUJ=IJVD7:QLZ3B*[M'D5;FWF#V]]:3E+
MJRNH9+6Z@@N8I8AVE !1110 445D:_KVD^%]"UGQ+K]];Z7H?A_2M0UK6-2N
MG$=M8:9I=K+>WUY/(Q 2*WMH999&)&%0T :]%?&W[+'QU^-?QFU3Q9>_%'X7
MZ!\.?"6L>%/!GQ/^#R:;K%_JOB*;X?>.O$7Q&T;0+'X@K<6T.FV?C670O ^B
M^,]0L="EN=/TJT\;V.ARSSW^E7=Q-]DT %%%(#DD<Y&,\<<^A[^_I0 #=DY
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MXW?!W2?".N^(]>^&>H:CK?PJ\:^&/&YU9/#7B+0I-6ACU[P/XANO[%NY=?\
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M,+\0_"/_  K/0HA=A7GFNM:\0W9WII\+,]U!IMG?W<LB?9;:*69UKXC\+_\
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?9>I^A--S\W_ ?ZT .HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
